Tagged with Hong Kong,

Hong Kong Frederic Charles, CEO of Pierre Fabre Hong Kong and Macau, outlines brand perceptions of Pierre Fabre’s dermatological products in Hong Kong, e-commerce, and other emerging skincare trends in Asia.   With the opening of Pierre Fabre Hong Kong affiliate in 2016, what were the main achievements so far? The affiliate…

Hong Kong Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind his company’s success.   Benjamin, as an industry veteran within the Hong Kong medical devices sector, with also a factory…

AstraZeneca Gwenael Meneux of AstraZeneca Hong Kong and Macau gives his initial impression of the HK market, outlines his unusual career trajectory and the new innovations AZ is looking to bring to patients in the region.   Gwenael, you have a very interesting and diverse background that is a bit atypical…

Innovation Andy A. Liu, CEO of CW Data Technologies, a joint venture between WuXi AppTec and China Electronics Data Corporation at the intersection of Big Data and healthcare, discusses emerging trends in healthcare technology and Hong Kong’s potential as an innovation incubator.   Andy, prior to your current role as CEO…

Hong Kong George Kwan, managing director of Hoya Lens, one of the first contact lens manufacturers in Hong Kong, introduces recent new innovation introduced to the market, public sector collaboration, and future strategy.   George, could you start by introducing Hoya Lens Hong Kong to our international audience? Hoya Lens Hong Kong…

Hong Kong Wolfgang Niedermark of GIC in Hong Kong, part of the AHK network of German Chambers of Commerce worldwide assesses the business relationship between Germany and Asia and how Hong Kong compares to its regional competitors as an investment destination What is your assessment of the business relationship between Germany and…

Hong Kong Matthew Man, CEO of Hong Kong cold chain monitoring technology specialist Myndar, expounds on the company’s formation, its differentiating factors, and countering resistance to new innovations in the healthcare sector.   How did you identify the niche in the market for your cold chain monitoring technologies? I founded Myndar back…

Hong Kong Professor James Chim, chairman and founder of the Hong Kong Society of Myeloma, shares the history and key objectives of the organization. He also elaborates on the recent milestones achieved regarding the treatment of the rare disease. Can you begin by introducing the Hong Kong Society of Myeloma and what…

Hong Kong Hye-ja Kim, Pfizer Pharmaceutical Innovative Health (Hong Kong and Macau Lead), shares how Pfizer’s global achievements in 2017 are reflected within the Hong Kong affiliate, the innovative solutions they can offer Hong Kong patients, government and other healthcare stakeholders beyond just a drug, and their continued commitment to extending their…

Hong Kong Dr. Sze-fai YIP, Chairman of the Hong Kong Society of Haematology (HKSH), shares the mission of the society to support healthcare professionals and other stakeholders within the area of haematology in order to drive better health outcomes, the challenges faced by haematology patients in Hong Kong, and the potential of…

Hong Kong Prof. Michael Yang, an accomplished scientist and start-up expert, introduces the goals of the fast-growing Biomedical Sciences Department of City University Hong Kong. He unveils the contribution of Hong Kong to the Greater Bay Area in the biomedical field, while analyzing the key elements to change so the region can…

Hong Kong Ian Huen, founder and CEO of Aptorum Group, discusses why Hong Kong was the ideal location to base the company, its exciting development pipeline and his unique management philosophy. Ian, with your asset management background, could you share what inspired you to establish Aptorum Group in 2016? My biotech journey…